FOLH1 and prostate cancer: In recent years, 68Ga-prostate-specific membrane antigen-11 PET (68Ga-PSMA-11 PET) and multiparametric MRI (mpMRI) have emerged as promising technologies in enhancing the accuracy of initial lymph node staging in prostate cancer (7).